Menu
Not yet recruiting NCT07642271

Effects of Sahrmann's Versus Janda Approach in Lower Crossed Syndrome Patients

No phase Interventional Lower Cross Syndrome

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Sahrmann's approach, Jandas approach.
Who it may be relevant to
Registry conditions: Lower Cross Syndrome. Basic parameters: 18 years — 40 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Pakistan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Sahrmann's Versus Janda Approach on Pain, Pelvic Tilt and Lumbar Lordosis in Lower Crossed Syndrome Patients

Overview

Muscular imbalance due to prolonged sitting or standing posture leads to a condition lower cross syndrome(LCS) or lumbopelvic syndrome. Several stretching and strengthening regimens are used to treat cross pattern of muscular tightness and weakness in LCS. This study aims to compare the effects of Sahrmann's versus Janda's approach on pain, pelvic tilt and lumbar lordosis in lower crossed syndrome patients.

Detailed description

This study will be a randomized clinical trial and will be conducted in physiotherapy department of Rasheed Hospital, DHA. Non probability convenience sampling will be used to collect data. Sample size of 54 with age group between 18 to 40 years will be taken. Data will be collected from the patient who fulfilled the criteria of LCS. Outcome measures will be taken by using Numeric Pain Rating Scale (NPRS) for pain, I Handy Level for Pelvic tilt, flexible ruler for lumbar angle. An informed consent will be taken. Subjects will be selected on the basis of inclusion and exclusion criteria and will be equally divided into two groups by random number generator table. Group A will receive Sahrmann's exercise protocol while group B will receive Janda's Approach. Both groups will receive 10 mins heating pad and 10 mins Tens for muscle relaxation. Outcome measures will be measured at baseline and then at 4th week. Data Analysis will be done by IBM SPSS version 21.

Interventions

  • Other Sahrmann's approach
    1. single knee to chest and double knee to chest 2. Rectus femoris stretching 3. kneeling psoas stretch 4. piriformis stretch in pigeon pose 5. lying piriformis stretch 6. Sit and reach stretch 1.Clamshell (side lying) strengthening of gluteus medius 2.Hip abduction gluteus medius strengthening 3.Extension of femur 4.isometric abdominal contraction(top to floor) 5. abdominal contraction(cat exercise)
  • Other Jandas approach
    1.50 to 70 degrees of trunk flexion 2.Pelvis tilting 3.One leg standing 4.Quadreped position (forward and backward movement) 5. Quadruped position (raising opposite arm and leg) 6. pelvic bridging 7.One leg bridge 8.Side Plank 9.Abdominal bracing 10. Knee active bending 90 degrees 11. Half Crunch

Primary outcome measures

  • Numeric pain rate scale (NPRS) for pain [Time frame: upto 4 weeks]
  • Flexible Ruler for lumbar Lordosis (degree) [Time frame: upto 4 weeks]
  • I Handy Level for Pelvic tilt(degree) [Time frame: upto 4 weeks]

Eligibility criteria

Inclusion criteria

  • • Gender (both)
  • Age (18 to 40)
  • Participants who fulfilled the criteria of lower cross syndrome

Exclusion criteria

  • • Any serious pathology i.e. Neoplasm
  • Any history of trauma
  • Spinal malalignment i.e. Scoliosis
  • Receiving any other form of Physical therapy treatment

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Pakistan · 1 center
  • Rasheed Hospital — Lahore

Publications

  • Kandil EA, Yamany AAER, Alsaka SSD, Abd El-Azeim AS. Effect of global postural reeducation on chronic low pain patients with lower cross syndrome. Bulletin of Faculty of Physical Therapy. 2024;29(1):8.
  • Sugavanam T, Sannasi R, Anand PA, Ashwin Javia P. Postural asymmetry in low back pain - a systematic review and meta-analysis of observational studies. Disabil Rehabil. 2025 Apr;47(7):1659-1676. doi: 10.1080/09638288.2024.2385070. Epub 2024 Aug 21. PMID 39166267
  • Nourbakhsh MR, Arabloo AM, Salavati M. The relationship between pelvic cross syndrome and chronic low back pain. Journal of Back and Musculoskeletal Rehabilitation. 2006;19(4):119-28.
  • Pradeep S, Heggannavar A, Metgud S. Effect of Sciatic Nerve Neurodynamic Sustained Natural Apophyseal Glides on Individuals with Pelvic Crossed Syndrome: A Randomized Controlled Trial. Indian Journal of Physical Therapy and Research. 2020;2(1):35-40.
  • Puagprakong P, Earde P, Kooncumchoo P, editors. Lumbo-Pelvic-Hip Angle Changes During Upright and Free Style Sitting in Office Workers with Lower Crossed Syndrome. Human Interaction, Emerging Technologies and Future Applications IV; 2021 2021//; Cham: Springer International Publishing.
  • Childs JD, Piva SR, Fritz JM. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine (Phila Pa 1976). 2005 Jun 1;30(11):1331-4. doi: 10.1097/01.brs.0000164099.92112.29. PMID 15928561
  • Seidi F, Rajabi R, Ts E, Sj M. Iranian Flexible ruler Reliability and Validity in Lumbar Lordosis Measurement. World Journal of Sport Sciences. 2009;2:95-9.
  • Lewandrowski KU, Elfar JC, Li ZM, Burkhardt BW, Lorio MP, Winkler PA, Oertel JM, Telfeian AE, Dowling A, Vargas RAA, Ramina R, Abraham I, Assefi M, Yang H, Zhang X, Ramirez Leon JF, Fiorelli RKA, Pereira MG, de Carvalho PST, Defino H, Moyano J, Lim KT, Kim HS, Montemurro N, Yeung A, Novellino P. The Changing Environment in Postgraduate Education in Orthopedic Surgery and Neurosurgery and Its Impac PMID 37241022

Identifiers

NCT: NCT07642271 · REC/RCR&AHS/25/0113 Rahila

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗